TreeWAS – Variant ID: rs36093844

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E10 Insulin-dependent diabetes mellitus	0.000	0.782	0.218
E10-E14 Diabetes mellitus	0.000	0.783	0.217
E11 Non-insulin-dependent diabetes mellitus	0.000	0.783	0.217
E11.6 With other specified complications	0.000	0.791	0.209
E10.4 With neurological complications	0.000	0.792	0.208
E14 Unspecified diabetes mellitus	0.000	0.794	0.206
E11.1 With ketoacidosis	0.000	0.797	0.203
E10.2 With renal complications	0.000	0.801	0.198
E14.9 Without complications	0.000	0.804	0.196
E10.1 With ketoacidosis	0.000	0.809	0.191
E10.3 With ophthalmic complications	0.000	0.811	0.189
E11.8 With unspecified complications	0.000	0.813	0.187
E11.2 With renal complications	0.000	0.814	0.185
E11.0 With coma	0.000	0.819	0.181
E10.8 With unspecified complications	0.000	0.828	0.172
E14.3 With ophthalmic complications	0.000	0.834	0.166
E14.8 With unspecified complications	0.000	0.836	0.164
E11.5 With peripheral circulatory complications	0.000	0.838	0.162
E13 Other specified diabetes mellitus	0.000	0.843	0.157
E10.7 With multiple complications	0.000	0.844	0.156
E14.6 With other specified complications	0.000	0.844	0.156
E12 Malnutrition-related diabetes mellitus	0.000	0.844	0.156
E11.7 With multiple complications	0.000	0.844	0.155
E14.5 With peripheral circulatory complications	0.000	0.846	0.154
E10.6 With other specified complications	0.000	0.848	0.151
E10.5 With peripheral circulatory complications	0.000	0.851	0.149
E14.7 With multiple complications	0.000	0.852	0.148
E14.0 With coma	0.000	0.852	0.148
E10.0 With coma	0.000	0.860	0.139
E14.4 With neurological complications	0.000	0.861	0.139
E14.2 Withrenal complications	0.000	0.864	0.136
E11.3 With ophthalmic complications	0.000	0.873	0.127
E14.1 With ketoacidosis	0.000	0.881	0.119
E13.9 Without complications	0.000	0.886	0.114
E13.8 With unspecified complications	0.000	0.887	0.113
E13.7 With multiple complications	0.000	0.887	0.113
E13.6 With other specified complications	0.000	0.887	0.113
E13.5 With peripheral circulatory complications	0.000	0.887	0.113
E13.4 With neurological complications	0.000	0.887	0.113
E13.3 With ophthalmic complications	0.000	0.887	0.113
E13.2 With renal complications	0.000	0.887	0.113
E13.1 With ketoacidosis	0.000	0.887	0.113
E13.0 With coma	0.000	0.887	0.113
E12.9 Without complications	0.000	0.888	0.112
E12.8 With unspecified complications	0.000	0.888	0.112
E12.7 With multiple complications	0.000	0.888	0.112
E12.6 With other specified complications	0.000	0.888	0.112
E12.5 With peripheral circulatory complications	0.000	0.888	0.112
E12.4 With neurological complications	0.000	0.888	0.112
E12.3 With ophthalmic complications	0.000	0.888	0.112
E12.2 With renal complications	0.000	0.888	0.112
E12.1 With ketoacidosis	0.000	0.888	0.112
E12.0 With coma	0.000	0.888	0.112
E11.4 With neurological complications	0.000	0.899	0.101
E10.9 Without complications	0.000	0.936	0.064
C09.9 Tonsil, unspecified	0.000	0.988	0.012
T43.2 Other and unspecified antidepressants	0.012	0.988	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.011	0.989	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.011	0.989	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.011	0.989	0.000
M62.88 Other specified disorders of muscle (Other)	0.000	0.989	0.011
Z12.8 Special screening examination for neoplasm of other sites	0.000	0.989	0.011
M62.8 Other specified disorders of muscle	0.000	0.990	0.010
M62.81 Other specified disorders of muscle (Shoulder region)	0.000	0.990	0.010
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.010	0.990	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.009	0.991	0.000
M62.80 Other specified disorders of muscle (Multiple sites)	0.000	0.991	0.009
M62.86 Other specified disorders of muscle (Lower leg)	0.000	0.991	0.009
Z36.0 Antenatal screening for chromosomal anomalies	0.000	0.992	0.008
T43.9 Psychotropic drug, unspecified	0.008	0.992	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.008	0.992	0.000
C09 Malignant neoplasm of tonsil	0.000	0.992	0.008
M62.85 Other specified disorders of muscle (Pelvic region and thigh)	0.000	0.992	0.008
M62.87 Other specified disorders of muscle (Ankle and foot)	0.000	0.992	0.007
M62.83 Other specified disorders of muscle (Forearm)	0.000	0.992	0.007
K65.0 Acute peritonitis	0.008	0.992	0.000
M62.84 Other specified disorders of muscle (Hand)	0.000	0.992	0.007
M62.89 Other specified disorders of muscle (Site unspecified)	0.000	0.993	0.007
M62.82 Other specified disorders of muscle (Upper arm)	0.000	0.993	0.007
S66.3 Injury of extensor muscle and tendon of other finger at wrist and hand level	0.000	0.993	0.007
T50.9 Other and unspecified drugs, medicaments and biological substances	0.007	0.993	0.000
N83.2 Other and unspecified ovarian cysts	0.000	0.993	0.007
H40.9 Glaucoma, unspecified	0.007	0.993	0.000
T43.6 Psychostimulants with abuse potential	0.006	0.993	0.000
K65 Peritonitis	0.006	0.994	0.000
Z87.7 Personal history of congenital malformations, deformations and chromosomal abnormalities	0.000	0.994	0.006
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.006	0.994	0.000
Z47.0 Follow-up care involving removal of fracture plate and other internal fixation device	0.000	0.994	0.006
H47.0 Disorders of optic nerve, not elsewhere classified	0.006	0.994	0.000
C09.8 Overlapping lesion of tonsil	0.000	0.994	0.006
C09.1 Tonsillar pillar (anterior) (posterior)	0.000	0.994	0.006
C09.0 Tonsillar fossa	0.000	0.994	0.006
K65.8 Other peritonitis	0.006	0.994	0.000
M65.34 Trigger finger-Hand	0.000	0.994	0.006
K65.9 Peritonitis, unspecified	0.006	0.994	0.000
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.000	0.994	0.006
H59.8 Other postprocedural disorders of eye and adnexa	0.006	0.994	0.000
T50.4 Drugs affecting uric acid metabolism	0.005	0.994	0.000
S66 Injury of muscle and tendon at wrist and hand level	0.000	0.994	0.005
S66.2 Injury of extensor muscle and tendon of thumb at wrist and hand level	0.000	0.995	0.005
M13.00 Polyarthritis, unspecified (Multiple sites)	0.005	0.995	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.005	0.995	0.000
I78.1 Naevus, nonneoplastic	0.000	0.995	0.005
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.005	0.995	0.000
S66.6 Injury of multiple flexor muscles and tendons at wrist and hand level	0.000	0.995	0.005
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.005	0.995	0.000
S66.7 Injury of multiple extensor muscles and tendons at wrist and hand level	0.000	0.995	0.005
C14.0 Pharynx, unspecified	0.000	0.995	0.005
T50.8 Diagnostic agents	0.005	0.995	0.000
T50.7 Analeptics and opioid receptor antagonists	0.005	0.995	0.000
T50.5 Appetite depressants	0.005	0.995	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.005	0.995	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.005	0.995	0.000
T50.1 Loop [high-ceiling] diuretics	0.005	0.995	0.000
T50.0 Mineralocorticoids and their antagonists	0.005	0.995	0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.000	0.995	0.005
T50.6 Antidotes and chelating agents, not elsewhere classified	0.005	0.995	0.000
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.000	0.995	0.005
E11.9 Without complications	0.000	0.995	0.005
S66.9 Injury of unspecified muscle and tendon at wrist and hand level	0.000	0.995	0.005
T43.0 Tricyclic and tetracyclic antidepressants	0.004	0.996	0.000
T36 Poisoning by systemic antibiotics	0.004	0.996	0.000
M13.0 Polyarthritis, unspecified	0.004	0.996	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.004	0.996	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.004	0.996	0.000
Z36 Antenatal screening	0.000	0.996	0.004
S66.0 Injury of long flexor muscle and tendon of thumb at wrist and hand level	0.000	0.996	0.004
C78.2 Secondary malignant neoplasm of pleura	0.000	0.996	0.004
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.004	0.996	0.000
C07 Malignant neoplasm of parotid gland	0.000	0.996	0.004
S66.5 Injury of intrinsic muscle and tendon of other finger at wrist and hand level	0.000	0.996	0.004
S66.4 Injury of intrinsic muscle and tendon of thumb at wrist and hand level	0.000	0.996	0.004
M13.09 Polyarthritis, unspecified (Site unspecified)	0.004	0.996	0.000
C10 Malignant neoplasm of oropharynx	0.000	0.996	0.004
C04 Malignant neoplasm of floor of mouth	0.000	0.996	0.004
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.004	0.996	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.004	0.996	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.004	0.996	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.004	0.996	0.000
T45.2 Vitamins, not elsewhere classified	0.004	0.996	0.000
Z12 Special screening examination for neoplasms	0.000	0.996	0.004
M79.84 Other specified soft tissue disorders (Hand)	0.004	0.996	0.000
T17.2 Foreign body in pharynx	0.000	0.996	0.004
T38.9 Other and unspecified hormone antagonists	0.004	0.996	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.004	0.996	0.000
T38.7 Androgens and anabolic congeners	0.004	0.996	0.000
T38.5 Other oestrogens and progestogens	0.004	0.996	0.000
T38.4 Oral contraceptives	0.004	0.996	0.000
T38.2 Antithyroid drugs	0.004	0.996	0.000
T38.0 Glucocorticoids and synthetic analogues	0.004	0.996	0.000
T47.0 Histamine H(2)-receptor antagonists	0.004	0.996	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.004	0.996	0.000
M13.06 Polyarthritis, unspecified (Lower leg)	0.004	0.996	0.000
M62 Other disorders of muscle	0.000	0.996	0.004
C05 Malignant neoplasm of palate	0.000	0.996	0.004
C11 Malignant neoplasm of nasopharynx	0.000	0.996	0.004
C10.9 Oropharynx, unspecified	0.000	0.996	0.004
C08 Malignant neoplasm of other and unspecified major salivary glands	0.000	0.996	0.004
T36.0 Penicillins	0.004	0.996	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.004	0.996	0.000
C14.8 Overlapping lesion of lip, oral cavity and pharynx	0.000	0.996	0.003
C14.2 Waldeyer's ring	0.000	0.996	0.003
C04.9 Floor of mouth, unspecified	0.000	0.996	0.004
C06 Malignant neoplasm of other and unspecified parts of mouth	0.000	0.996	0.004
H47 Other disorders of optic [2nd] nerve and visual pathways	0.004	0.996	0.000
L85.9 Epidermal thickening, unspecified	0.004	0.996	0.000
I45.1 Other and unspecified right bundle-branch block	0.004	0.996	0.000
T38.1 Thyroid hormones and substitutes	0.003	0.996	0.000
T45.0 Antiallergic and antiemetic drugs	0.003	0.996	0.000
C03 Malignant neoplasm of gum	0.000	0.996	0.003
C12 Malignant neoplasm of pyriform sinus	0.000	0.996	0.003
Z36.1 Antenatal screening for raised alphafetoprotein level	0.000	0.997	0.003
N31.8 Other neuromuscular dysfunction of bladder	0.000	0.997	0.003
Z12.2 Special screening examination for neoplasm of respiratory organs	0.000	0.997	0.003
Z36.2 Other antenatal screening based on amniocentesis	0.000	0.997	0.003
C13 Malignant neoplasm of hypopharynx	0.000	0.997	0.003
S66.8 Injury of other muscles and tendons at wrist and hand level	0.000	0.997	0.003
T45.5 Anticoagulants	0.003	0.997	0.000
M13.08 Polyarthritis, unspecified (Other)	0.003	0.997	0.000
M13.07 Polyarthritis, unspecified (Ankle and foot)	0.003	0.997	0.000
M13.05 Polyarthritis, unspecified (Pelvic region and thigh)	0.003	0.997	0.000
M13.04 Polyarthritis, unspecified (Hand)	0.003	0.997	0.000
M13.03 Polyarthritis, unspecified (Forearm)	0.003	0.997	0.000
M13.02 Polyarthritis, unspecified (Upper arm)	0.003	0.997	0.000
M13.01 Polyarthritis, unspecified (Shoulder region)	0.003	0.997	0.000
T36.9 Systemic antibiotic, unspecified	0.003	0.997	0.000
T36.8 Other systemic antibiotics	0.003	0.997	0.000
T36.7 Antifungal antibiotics, systemically used	0.003	0.997	0.000
T36.6 Rifamycins	0.003	0.997	0.000
T36.5 Aminoglycosides	0.003	0.997	0.000
T36.4 Tetracyclines	0.003	0.997	0.000
T36.3 Macrolides	0.003	0.997	0.000
T36.2 Chloramphenicol group	0.003	0.997	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.003	0.997	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.003	0.997	0.000
T45.8 Other primarily systemic and haematological agents	0.003	0.997	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.997	0.000
T45.6 Fibrinolysis-affecting drugs	0.003	0.997	0.000
T45.4 Iron and its compounds	0.003	0.997	0.000
T45.3 Enzymes, not elsewhere classified	0.003	0.997	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.003	0.997	0.000
T48.5 Anti-common-cold drugs	0.003	0.997	0.000
T48.4 Expectorants	0.003	0.997	0.000
T48.3 Antitussives	0.003	0.997	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.003	0.997	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.003	0.997	0.000
T48.0 Oxytocic drugs	0.003	0.997	0.000
Z36.5 Antenatal screening for isoimmunisation	0.000	0.997	0.003
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
T47.7 Emetics	0.003	0.997	0.000
T47.6 Antidiarrhoeal drugs	0.003	0.997	0.000
T47.5 Digestants	0.003	0.997	0.000
T47.4 Other laxatives	0.003	0.997	0.000
T47.3 Saline and osmotic laxatives	0.003	0.997	0.000
T47.2 Stimulant laxatives	0.003	0.997	0.000
Z12.5 Special screening examination for neoplasm of prostate	0.000	0.997	0.003
Z12.6 Special screening examination for neoplasm of bladder	0.000	0.997	0.003
O75.6 Delayed delivery after spontaneous or unspecified rupture of membranes	0.000	0.997	0.003
C01 Malignant neoplasm of base of tongue	0.000	0.997	0.003
Z12.9 Special screening examination for neoplasm, unspecified	0.000	0.997	0.003
C10.8 Overlapping lesion of oropharynx	0.000	0.997	0.003
C10.4 Branchial cleft	0.000	0.997	0.003
C10.3 Posterior wall of oropharynx	0.000	0.997	0.003
C10.2 Lateral wall of oropharynx	0.000	0.997	0.003
C10.1 Anterior surface of epiglottis	0.000	0.997	0.003
C10.0 Vallecula	0.000	0.997	0.003
C04.8 Overlapping lesion of floor of mouth	0.000	0.997	0.003
C04.1 Lateral floor of mouth	0.000	0.997	0.003
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.003	0.997	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.997	0.000
T37.5 Antiviral drugs	0.003	0.997	0.000
T37.4 Anthelminthics	0.003	0.997	0.000
T37.3 Other antiprotozoal drugs	0.003	0.997	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.003	0.997	0.000
T37.1 Antimycobacterial drugs	0.003	0.997	0.000
T37.0 Sulphonamides	0.003	0.997	0.000
T41.5 Therapeutic gases	0.003	0.997	0.000
T41.4 Anaesthetic, unspecified	0.003	0.997	0.000
T41.3 Local anaesthetics	0.003	0.997	0.000
T41.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
T41.1 Intravenous anaesthetics	0.003	0.997	0.000
T41.0 Inhaled anaesthetics	0.003	0.997	0.000
T49.9 Topical agent, unspecified	0.003	0.997	0.000
T49.8 Other topical agents	0.003	0.997	0.000
T49.7 Dental drugs, topically applied	0.003	0.997	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.003	0.997	0.000
T49.5 Ophthalmological drugs and preparations	0.003	0.997	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.997	0.000
T49.3 Emollients, demulcents and protectants	0.003	0.997	0.000
T49.2 Local astringents and local detergents	0.003	0.997	0.000
T49.1 Antipruritics	0.003	0.997	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.003	0.997	0.000
Z12.4 Special screening examination for neoplasm of cervix	0.000	0.997	0.003
C05.1 Soft palate	0.000	0.997	0.003
C45.0 Mesothelioma of pleura	0.000	0.997	0.003
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.003	0.997	0.000
Z12.3 Special screening examination for neoplasm of breast	0.000	0.997	0.003
M65.3 Trigger finger	0.000	0.997	0.003
C04.0 Anterior floor of mouth	0.000	0.997	0.003
C00 Malignant neoplasm of lip	0.000	0.997	0.003
H47.1 Papilloedema, unspecified	0.003	0.997	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.003	0.997	0.000
C06.9 Mouth, unspecified	0.000	0.997	0.003
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.003	0.997	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.003	0.997	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.003	0.997	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.003	0.997	0.000
T44.0 Anticholinesterase agents	0.003	0.997	0.000
C11.9 Nasopharynx, unspecified	0.000	0.997	0.003
M62.4 Contracture of muscle	0.000	0.997	0.003
M62.3 Immobility syndrome (paraplegic)	0.000	0.997	0.003
M62.2 Ischaemic infarction of muscle	0.000	0.997	0.003
M62.0 Diastasis of muscle	0.000	0.997	0.003
C05.8 Overlapping lesion of palate	0.000	0.997	0.003
C05.2 Uvula	0.000	0.997	0.003
C05.0 Hard palate	0.000	0.997	0.003
N77.1 Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere	0.000	0.997	0.003
C11.8 Overlapping lesion of nasopharynx	0.000	0.997	0.003
C11.3 Anterior wall of nasopharynx	0.000	0.997	0.003
C11.2 Lateral wall of nasopharynx	0.000	0.997	0.003
C11.1 Posterior wall of nasopharynx	0.000	0.997	0.003
C11.0 Superior wall of nasopharynx	0.000	0.997	0.003
C08.9 Major salivary gland, unspecified	0.000	0.997	0.003
C08.8 Overlapping lesion of major salivary glands	0.000	0.997	0.003
C08.1 Sublingual gland	0.000	0.997	0.003
C08.0 Submandibular gland	0.000	0.997	0.003
N88.2 Stricture and stenosis of cervix uteri	0.003	0.997	0.000
C05.9 Palate, unspecified	0.000	0.997	0.003
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods	0.000	0.997	0.003
C06.2 Retromolar area	0.000	0.997	0.003
T47.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
C06.8 Overlapping lesion of other and unspecified parts of mouth	0.000	0.997	0.003
C06.1 Vestibule of mouth	0.000	0.997	0.003
H47.7 Disorder of visual pathways, unspecified	0.003	0.997	0.000
H47.6 Disorders of visual cortex	0.003	0.997	0.000
H47.5 Disorders of other visual pathways	0.003	0.997	0.000
H47.4 Disorders of optic chiasm	0.003	0.997	0.000
M62.1 Other rupture of muscle (nontraumatic)	0.000	0.997	0.003
M62.9 Disorder of muscle, unspecified	0.000	0.997	0.003
M62.5 Muscle wasting and atrophy, not elsewhere classified	0.000	0.997	0.003
T46 Poisoning by agents primarily affecting the cardiovascular system	0.003	0.997	0.000
C03.9 Gum, unspecified	0.000	0.997	0.003
C03.0 Upper gum	0.000	0.997	0.003
C22.9 Liver, unspecified	0.000	0.997	0.003
M62.6 Muscle strain	0.000	0.997	0.003
C45.9 Mesothelioma, unspecified	0.000	0.997	0.003
H47.2 Optic atrophy	0.003	0.997	0.000
C13.9 Hypopharynx, unspecified	0.000	0.997	0.003
C13.8 Overlapping lesion of hypopharynx	0.000	0.997	0.003
C13.2 Posterior wall of hypopharynx	0.000	0.997	0.003
C13.1 Aryepiglottic fold, hypopharyngeal aspect	0.000	0.997	0.003
N83 Noninflammatory disorders of ovary, Fallopian tube and broad ligament	0.000	0.997	0.003
Z12.0 Special screening examination for neoplasm of stomach	0.000	0.997	0.003
H47.3 Other disorders of optic disk	0.003	0.997	0.000
C02 Malignant neoplasm of other and unspecified parts of tongue	0.000	0.997	0.003
I78 Diseases of capillaries	0.000	0.997	0.003
N83.5 Torsion of ovary, ovarian pedicle and Fallopian tube	0.000	0.997	0.003
L65.9 Nonscarring hair loss, unspecified	0.003	0.997	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.002	0.997	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.002	0.997	0.000
C03.1 Lower gum	0.000	0.997	0.002
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified	0.003	0.997	0.000
I45.2 Bifascicular block	0.003	0.997	0.000
C45 Mesothelioma	0.000	0.997	0.003
C06.0 Cheek mucosa	0.000	0.997	0.002
M65.39 Trigger finger-Site unspec	0.000	0.997	0.002
M65.38 Trigger finger-Other	0.000	0.997	0.002
M65.37 Trigger finger-Ankle/foot	0.000	0.997	0.002
M65.36 Trigger finger-Lower leg	0.000	0.997	0.002
M65.35 Trigger finger-Pelvic/thigh	0.000	0.997	0.002
M65.33 Trigger finger-Forearm	0.000	0.997	0.002
M65.32 Trigger finger-Upper arm	0.000	0.997	0.002
M65.31 Trigger finger-Shldr region	0.000	0.997	0.002
M65.30 Trigger finger-Mult sites	0.000	0.997	0.002
C00.8 Overlapping lesion of lip	0.000	0.997	0.002
C00.6 Commissure of lip	0.000	0.997	0.002
C00.5 Lip, unspecified, inner aspect	0.000	0.997	0.002
C00.4 Lower lip, inner aspect	0.000	0.997	0.002
C00.3 Upper lip, inner aspect	0.000	0.997	0.002
C00.2 External lip, unspecified	0.000	0.997	0.002
C00.0 External upper lip	0.000	0.997	0.002
C13.0 Postcricoid region	0.000	0.997	0.002
Z48.0 Attention to surgical dressings and sutures	0.000	0.997	0.002
N83.3 Acquired atrophy of ovary and Fallopian tube	0.000	0.998	0.002
S46.0 Injury of tendon of the rotator cuff of shoulder	0.002	0.998	0.000
M62.09 Diastasis of muscle (Site unspecified)	0.000	0.998	0.002
M62.08 Diastasis of muscle (Other)	0.000	0.998	0.002
M62.07 Diastasis of muscle (Ankle and foot)	0.000	0.998	0.002
M62.06 Diastasis of muscle (Lower leg)	0.000	0.998	0.002
M62.05 Diastasis of muscle (Pelvic region and thigh)	0.000	0.998	0.002
M62.04 Diastasis of muscle (Hand)	0.000	0.998	0.002
M62.03 Diastasis of muscle (Forearm)	0.000	0.998	0.002
M62.02 Diastasis of muscle (Upper arm)	0.000	0.998	0.002
M62.01 Diastasis of muscle (Shoulder region)	0.000	0.998	0.002
M62.00 Diastasis of muscle (Multiple sites)	0.000	0.998	0.002
M62.29 Ischaemic infarction of muscle (Site unspecified)	0.000	0.998	0.002
M62.28 Ischaemic infarction of muscle (Other)	0.000	0.998	0.002
M62.27 Ischaemic infarction of muscle (Ankle and foot)	0.000	0.998	0.002
M62.26 Ischaemic infarction of muscle (Lower leg)	0.000	0.998	0.002
M62.25 Ischaemic infarction of muscle (Pelvic region and thigh)	0.000	0.998	0.002
M62.24 Ischaemic infarction of muscle (Hand)	0.000	0.998	0.002
M62.23 Ischaemic infarction of muscle (Forearm)	0.000	0.998	0.002
M62.22 Ischaemic infarction of muscle (Upper arm)	0.000	0.998	0.002
M62.21 Ischaemic infarction of muscle (Shoulder region)	0.000	0.998	0.002
M62.20 Ischaemic infarction of muscle (Multiple sites)	0.000	0.998	0.002
M62.39 Immobility syndrome (paraplegic) (Site unspecified)	0.000	0.998	0.002
M62.38 Immobility syndrome (paraplegic) (Other)	0.000	0.998	0.002
M62.37 Immobility syndrome (paraplegic) (Ankle and foot)	0.000	0.998	0.002
M62.36 Immobility syndrome (paraplegic) (Lower leg)	0.000	0.998	0.002
M62.35 Immobility syndrome (paraplegic) (Pelvic region and thigh)	0.000	0.998	0.002
M62.34 Immobility syndrome (paraplegic) (Hand)	0.000	0.998	0.002
M62.33 Immobility syndrome (paraplegic) (Forearm)	0.000	0.998	0.002
M62.32 Immobility syndrome (paraplegic) (Upper arm)	0.000	0.998	0.002
M62.31 Immobility syndrome (paraplegic) (Shoulder region)	0.000	0.998	0.002
M62.30 Immobility syndrome (paraplegic) (Multiple sites)	0.000	0.998	0.002
M62.49 Contracture of muscle (Site unspecified)	0.000	0.998	0.002
M62.48 Contracture of muscle (Other)	0.000	0.998	0.002
M62.47 Contracture of muscle (Ankle and foot)	0.000	0.998	0.002
M62.46 Contracture of muscle (Lower leg)	0.000	0.998	0.002
M62.45 Contracture of muscle (Pelvic region and thigh)	0.000	0.998	0.002
M62.44 Contracture of muscle (Hand)	0.000	0.998	0.002
M62.43 Contracture of muscle (Forearm)	0.000	0.998	0.002
M62.42 Contracture of muscle (Upper arm)	0.000	0.998	0.002
M62.41 Contracture of muscle (Shoulder region)	0.000	0.998	0.002
M62.40 Contracture of muscle (Multiple sites)	0.000	0.998	0.002
I78.0 Hereditary haemorrhagic telangiectasia	0.000	0.998	0.002
Z47 Other orthopaedic follow-up care	0.000	0.998	0.002
M62.50 Muscle wasting and atrophy, not elsewhere classified (Multiple sites)	0.000	0.998	0.002
Q23.1 Congenital insufficiency of aortic valve	0.000	0.998	0.002
M62.19 Other rupture of muscle (nontraumatic) (Site unspecified)	0.000	0.998	0.002
M62.18 Other rupture of muscle (nontraumatic) (Other)	0.000	0.998	0.002
M62.17 Other rupture of muscle (nontraumatic) (Ankle and foot)	0.000	0.998	0.002
M62.16 Other rupture of muscle (nontraumatic) (Lower leg)	0.000	0.998	0.002
M62.15 Other rupture of muscle (nontraumatic) (Pelvic region and thigh)	0.000	0.998	0.002
M62.14 Other rupture of muscle (nontraumatic) (Hand)	0.000	0.998	0.002
M62.13 Other rupture of muscle (nontraumatic) (Forearm)	0.000	0.998	0.002
M62.12 Other rupture of muscle (nontraumatic) (Upper arm)	0.000	0.998	0.002
M62.10 Other rupture of muscle (nontraumatic) (Multiple sites)	0.000	0.998	0.002
S02.10 Fracture of base of skull (closed)	0.000	0.998	0.002
C00.1 External lower lip	0.000	0.998	0.002
C80.9 Malignant neoplasm, unspecified	0.000	0.998	0.002
M62.59 Muscle wasting and atrophy, not elsewhere classified (Site unspecified)	0.000	0.998	0.002
M62.58 Muscle wasting and atrophy, not elsewhere classified (Other)	0.000	0.998	0.002
M62.57 Muscle wasting and atrophy, not elsewhere classified (Ankle and foot)	0.000	0.998	0.002
M62.56 Muscle wasting and atrophy, not elsewhere classified (Lower leg)	0.000	0.998	0.002
M62.55 Muscle wasting and atrophy, not elsewhere classified (Pelvic region and thigh)	0.000	0.998	0.002
M62.53 Muscle wasting and atrophy, not elsewhere classified (Forearm)	0.000	0.998	0.002
M62.52 Muscle wasting and atrophy, not elsewhere classified (Upper arm)	0.000	0.998	0.002
M62.51 Muscle wasting and atrophy, not elsewhere classified (Shoulder region)	0.000	0.998	0.002
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.000	0.998	0.002
M62.98 Disorder of muscle, unspecified (Other)	0.000	0.998	0.002
M62.97 Disorder of muscle, unspecified (Ankle and foot)	0.000	0.998	0.002
M62.96 Disorder of muscle, unspecified (Lower leg)	0.000	0.998	0.002
M62.95 Disorder of muscle, unspecified (Pelvic region and thigh)	0.000	0.998	0.002
M62.94 Disorder of muscle, unspecified (Hand)	0.000	0.998	0.002
M62.93 Disorder of muscle, unspecified (Forearm)	0.000	0.998	0.002
M62.92 Disorder of muscle, unspecified (Upper arm)	0.000	0.998	0.002
M62.91 Disorder of muscle, unspecified (Shoulder region)	0.000	0.998	0.002
M62.90 Disorder of muscle, unspecified (Multiple sites)	0.000	0.998	0.002
C78.1 Secondary malignant neoplasm of mediastinum	0.000	0.998	0.002
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
T46.7 Peripheral vasodilators	0.002	0.998	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.002	0.998	0.000
M62.69 Muscle strain (Site unspecified)	0.000	0.998	0.002
M62.68 Muscle strain (Other)	0.000	0.998	0.002
M62.67 Muscle strain (Ankle and foot)	0.000	0.998	0.002
M62.66 Muscle strain (Lower leg)	0.000	0.998	0.002
M62.64 Muscle strain (Hand)	0.000	0.998	0.002
M62.63 Muscle strain (Forearm)	0.000	0.998	0.002
M62.62 Muscle strain (Upper arm)	0.000	0.998	0.002
M62.61 Muscle strain (Shoulder region)	0.000	0.998	0.002
M62.60 Muscle strain (Multiple sites)	0.000	0.998	0.002
S81.8 Open wound of other parts of lower leg	0.000	0.998	0.002
Y42.5 Other oestrogens and progestogens	0.000	0.998	0.002
Z99.1 Dependence on respirator	0.002	0.998	0.000
E28.2 Polycystic ovarian syndrome	0.000	0.998	0.002
T46.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
N83.7 Haematoma of broad ligament	0.000	0.998	0.002
N83.6 Haematosalpinx	0.000	0.998	0.002
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.000	0.998	0.002
C02.8 Overlapping lesion of tongue	0.000	0.998	0.002
C02.3 Anterior two-thirds of tongue, part unspecified	0.000	0.998	0.002
C02.0 Dorsal surface of tongue	0.000	0.998	0.002
C80.0 Malignant neoplasm, primary site unknown, so stated	0.000	0.998	0.002
H40.1 Primary open-angle glaucoma	0.002	0.998	0.000
M89.97 Disorder of bone, unspecified (Ankle and foot)	0.000	0.998	0.002
C45.7 Mesothelioma of other sites	0.000	0.998	0.002
I78.9 Disease of capillaries, unspecified	0.000	0.998	0.002
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.000	0.998	0.002
M62.11 Other rupture of muscle (nontraumatic) (Shoulder region)	0.000	0.998	0.002
M07.39 Other psoriatic arthropathies (Site unspecified)	0.002	0.998	0.000
C00.9 Lip, unspecified	0.000	0.998	0.002
N83.0 Follicular cyst of ovary	0.000	0.998	0.002
H59.0 Vitreous syndrome following cataract surgery	0.002	0.998	0.000
N85.4 Malposition of uterus	0.000	0.998	0.002
M62.99 Disorder of muscle, unspecified (Site unspecified)	0.000	0.998	0.002
C45.2 Mesothelioma of pericardium	0.000	0.998	0.002
C45.1 Mesothelioma of peritoneum	0.000	0.998	0.002
Z47.9 Orthopaedic follow-up care, unspecified	0.000	0.998	0.002
H40 Glaucoma	0.002	0.998	0.000
C02.4 Lingual tonsil	0.000	0.998	0.002
C22.1 Intrahepatic bile duct carcinoma	0.000	0.998	0.002
M62.54 Muscle wasting and atrophy, not elsewhere classified (Hand)	0.000	0.998	0.002
M62.65 Muscle strain (Pelvic region and thigh)	0.000	0.998	0.002
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.002	0.998	0.000
I45.4 Nonspecific intraventricular block	0.002	0.998	0.000
N83.9 Noninflammatory disorder of ovary, Fallopian tube and broad ligament, unspecified	0.000	0.998	0.002
N83.4 Prolapse and hernia of ovary and Fallopian tube	0.000	0.998	0.002
T46.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
I45 Other conduction disorders	0.002	0.998	0.000
C02.2 Ventral surface of tongue	0.000	0.998	0.002
C78.0 Secondary malignant neoplasm of lung	0.000	0.998	0.002
I78.8 Other diseases of capillaries	0.000	0.998	0.002
T40.4 Other synthetic narcotics	0.000	0.998	0.002
Y52.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
C02.9 Tongue, unspecified	0.000	0.998	0.002
I45.6 Preexcitation syndrome	0.002	0.998	0.000
L28.0 Lichen simplex chronicus	0.002	0.998	0.000
C80 Malignant neoplasm without specification of site	0.000	0.998	0.002
T42.1 Iminostilbenes	0.002	0.998	0.000
Z36.9 Antenatal screening, unspecified	0.000	0.998	0.002
H59.9 Postprocedural disorder of eye and adnexa, unspecified	0.002	0.998	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
O23.5 Infections of the genital tract in pregnancy	0.000	0.998	0.002
T42.5 Mixed antiepileptics, not elsewhere classified	0.002	0.998	0.000
T42.3 Barbiturates	0.002	0.998	0.000
T42.2 Succinimides and oxazolidinediones	0.002	0.998	0.000
C20 Malignant neoplasm of rectum	0.000	0.998	0.002
M79.87 Other specified soft tissue disorders (Ankle and foot)	0.002	0.998	0.000
T42.0 Hydantoin derivatives	0.002	0.998	0.000
D63.0 Anaemia in neoplastic disease	0.000	0.998	0.002
T46.1 Calcium-channel blockers	0.002	0.998	0.000
C22.7 Other specified carcinomas of liver	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations